Expressing IL15 under the control of the CD11c promoter ensures its expression in cell types, which physiologically do express the cytokine in a tightly regulated manner and also ensures the expression of the cytokine at organs and sites in which tumor immunity is occurring. The gene discussed is ITGAX; the disease is neoplasm.